Circulating fibulin-3 has been proposed as a biomarker candidate for MPM, both by primary studies (13, 28–30) and meta-analyses (31–33) of patient populations; however, the functions and potential mechanisms of fibulin-3 in this cancer type remain completely unknown. The gene discussed is EFEMP1; the disease is cancer.